Next-Generation Personalized Injection System
Legal Citation
Summary of the Inventive Concept
A wearable, AI-powered injection device that integrates physiological parameter detection, genomic analysis, and real-time dosage adjustment for personalized medicine.
Background and Problem Solved
The original patent disclosed a supplementary device for attachment to an injection device, enabling dosage selection and detection. However, it was limited to mechanical coupling and lacked advanced features for personalized medicine. The new inventive concept addresses these limitations by incorporating cutting-edge technologies to provide a more sophisticated and adaptive injection system.
Detailed Description of the Inventive Concept
The next-generation personalized injection system comprises a miniaturized injection module integrated with a sensor array to detect a patient's physiological parameters, such as glucose levels, blood pressure, and heart rate. The system is powered by an artificial intelligence algorithm that analyzes the patient's medical history, genomic data, and real-time physiological parameters to optimize the dosage and administration route. The system features interchangeable cartridges containing different medications, which are automatically detected and adapted to by the system. Additionally, the device includes a subcutaneous injection module with an integrated biosensor for continuous glucose level monitoring and automatic insulin administration. The handheld device also incorporates a microfluidic chip for real-time blood chemistry analysis and dosage adjustment.
Novelty and Inventive Step
The new claims introduce a paradigm shift in injection technology by integrating AI, genomic analysis, and real-time physiological parameter detection, making the original patent's mechanical coupling and dosage selection obsolete. The inventive concept's novelty lies in its ability to provide personalized medicine through advanced data analysis and adaptive dosage adjustment.
Alternative Embodiments and Variations
Alternative embodiments may include a smartphone app for remote monitoring and data analysis, a cloud-based platform for data storage and sharing, or a modular design allowing for easy upgrade and replacement of components. Variations may include different sensor arrays, AI algorithms, or medication cartridges tailored to specific medical conditions or patient populations.
Potential Commercial Applications and Market
The next-generation personalized injection system has significant commercial potential in the healthcare industry, particularly in the fields of diabetes management, personalized medicine, and pharmaceutical research. The market for such a system is vast, with potential applications in hospitals, clinics, and home care settings, as well as in the development of new medications and treatment protocols.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M5/3155 |
| A | A61 | A61M5/2033 |
| A | A61 | A61M2005/3126 |
| A | A61 | A61M2205/332 |
| A | A61 | A61M2205/3327 |
| A | A61 | A61M2205/3584 |
| A | A61 | A61M2205/52 |
| A | A61 | A61M2205/8206 |
Original Patent Information
| Patent Number | US 11,857,708 |
|---|---|
| Title | Device for attachment to an injection device |
| Assignee(s) | Sanofi |